Skip to main content
. 2024 Oct 8;25(1):174. doi: 10.1186/s10194-024-01862-8

Table 1.

The demographics and clinical profile data of all CH patients

Total
N = 168
Ability to predict the upcoming CH bouts p value*
Yes
N = 86 (51.2%)
No
N = 82 (48.8%)
Female sex, N (%) 39 (23.2%) 19 (22.1%) 20 (24.4%) 0.724 #
Age, mean (SD), years 38.5 (11.0) 37.9 (10.1) 39.1 (11.9) 0.492§
Disease duration, median (IQR), years 10 (5.0–17.0) 12 (6.8–18) 10 (4.0-15.3) 0.073###
Total experienced CH bouts, median (IQR) 8.5 (5.0–14.0) 8.5 (6.0–14.0) 8.5 (3.0–14.0) 0.287###
Duration of bout, median (IQR), months 1.5 (1.0–2.0) 1.8 (1.0-2.1) 1.5 (1.0–2.0) 0.078###
Attacks per day in bout, mean (SD) 2.1 (1.5) 2.0 (1.2) 2.1 (1.7) 0.504§
Attack duration without treatment, mean (SD), mins 118.0 (160.5) 112.2 (157.5) 124.2 (164.4) 0.632§
CHSS score, mean (SD) 5.96 (1.32) 5.92 (1.27) 6.00 (1.37) 0.690§
Circadian rhythmicity of CH attacks, % 105 (62.5%) 62 (72.1%) 43 (53.4%) 0.009# *
Seasonal rhythmicity of CH bouts, % 127 (75.6%) 64 (74.4%) 63 (76.8%) 0.716#
Comorbid migraine, n (%) 34 (20.2%) 21 (24.4%) 13 (15.9%) 0.167#
Out-of-bout shadow attacks, n (%) 58 (34.5%) 36 (41.9%) 22 (26.8%) 0.041 #*

CHSS: Cluster Headache Severity Scale

* p < 0.05 was considered to indicate statistical significance

# The differences in these categorical variables between patients who were able and unable to predict upcoming bouts were analyzed by the chi-square test

## The differences in these categorical variables between patients who were able and unable to predict upcoming bouts were

analyzed by Fisher’s exact test

### The Mann‒Whitney U test was used to compare nonnormally distributed continuous variables, and p < 0.05 was

considered to indicate statistical significance

§ The differences in these continuous variables between patients who were able and unable to predict upcoming bouts were

analyzed by t tests